ASTRA ZENECA EPSILON BV

Bob T. Li

Global Head of Medical Affairs, Oncology, AstraZeneca

David Brocklehurst

Vice President, Global Franchise Head, DDR & Gynaecological/Genitourinary Cancers

Dafni Bika

Senior Vice President and Global Head of Pharmaceutical Technology and Development (PT&D), Global Operations

Mark T. Esser

Vice President and Head of Microbial Sciences, BioPharmaceuticals R&D

Jorge Reis-Filho

Chief AI and Data Scientist, Oncology R&D, Astrazeneca

Rodolphe Grepinet

SVP Corporate Development

Matt Hellmann

Vice President, Early Oncology Development, AstraZeneca

Martin Cowie

Vice President Clinical Cardiovascular and Renal Clinical Development, BioPharmaceuticals R&D, AstraZeneca

Kay Tait

Executive Director, Transactions

Iskra Reic

Executive Vice-President, International

Ryan Hicks

Head of Bioscience Cell Therapy, BioPharmaceuticals R&D

Leora Horn

Global Clinical Head for Lung Cancer and Lung Cancer Strategy

Ingrid A. Mayer

Global Clinical Head for Breast Cancer and Breast Cancer Strategy

Jeff Pott

Chief Human Resources Officer, Chief Compliance Officer and General Counsel

Anas Younes

Senior Vice President, Global Head of Haematology (Early and Late Stage) Oncology R&D

Andrew Foxley

Vice President, Franchise Head, Late Oncology R&D

Adam Platt

VP and Head of Translational Science and Experimental Medicine, Respiratory and Immunology, AstraZeneca

Shin Morita

Vice President, Oncology Business Unit

Slavé Petrovski

VP, Centre for Genomics Research, BioPharmaceuticals R&D

Christopher J. Rhodes

Chief Scientist, Research and Early Development, Cardiovascular, Renal and Metabolism (CVRM), BioPharmaceuticals R&D, and Chair of AstraZeneca’s postdoc programme

Suzanne Cohen

Executive Director and Head of Bioscience Asthma and Skin Immunity, Respiratory and Immunology (R&I), AstraZeneca

Ratan Bhat

VP and Global Head of Business Development & Licensing, BioPharmaceuticals R&D

Kenny Hansson

Executive Director and Head of Bioscience Cardiovascular, Cardiovascular, Renal and Metabolism (CVRM), AstraZeneca

Michele Sample

VP, Late Stage Oncology Clinical Operations, AstraZeneca

Nathan Styles

Executive Director, Head of Search & Evaluation, CVRM, BioPharmaceuticals R&D

Nikhil Muthal

Executive Director, Head of Search & Evaluation, Respiratory & Immunology, BioPharmaceuticals R&D

Sharon Barr

Executive Vice-President, BioPharmaceuticals R&D

Ruth March

Senior-Vice President of Precision Medicine, R&D Oncology

Anne-Claire Gerbaldi

SVP GPPM, Strategic Planning, BDO and Deal Finance

Pascal Soriot

Executive Director and Chief Executive Officer

Ken Grime

Executive Director and Head of Bioscience COPD & IPF, Respiratory & Immunology (R&I), AstraZeneca

Gayatri Varma PhD

Executive Director, Head of Transactions Oncology Business Development

Susan Galbraith

Executive Vice-President, Oncology R&D

Ruud Dobber

Executive Vice-President, BioPharmaceuticals Business Unit

Sunil Verma

Senior Vice President, Global Head, Oncology Franchise, AstraZeneca

Caterina Brindicci

Senior Vice President and Global Head of R&I Late-Stage Development, BioPharmaceuticals R&D, AstraZeneca

Ben Challis

VP and Head of Translational Science & Experimental Medicine, Cardiovascular, Renal and Metabolism, AstraZeneca

Susanna Myhre

Head of Academic Partnership, BioPharmaceuticals R&D

Christopher Church

Head of Search & Evaluation, Technology, BioPharmaceuticals R&D

David Baker

Executive Director, Head of Bioscience Metabolism, Cardiovascular, Renal and Metabolism (CVRM), AstraZeneca

Malin Lemurell

Executive Director and Head of Medicinal Chemistry, Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D

Pam Cheng

Executive Vice President, Global Operations, IT & Chief Sustainability Officer

Mark Cobbold

Vice President, Discovery, Oncology R&D

Eniola Ashafa

PET Lead/Head of Manufacturing for Coppell Supply Site, AstraZeneca

Mark O’Connor

Chief Scientist, Early Oncology Discovery

Polly Brown

VP, Head of Business Development, Oncology R&D

Jim Weatherall

Chief Data Scientist, BioPharmaceuticals R&D, AstraZeneca

Lutz Jermutus

Head of Projects

Mina Makar

Senior Vice President, Global Cardiovascular, Renal and Metabolism (CVRM), BioPharmaceuticals Business Unit

Shawn Davis

Head of Drug Delivery, BioPharmaceuticals Development, R&D

Judy Campagnari

Executive Director, Head of Alliance and Integration Team (AIT)

Puja Sapra

Senior Vice President, Biologics Engineering & Oncology Targeted Discovery

Ian Kirk

VP, Business Development Sweden

Gemma Satterthwaite

Global Product Leader, Oncology Business Unit

David Fredrickson

Executive Vice-President, Oncology Business Unit

Tonya Villafana

Vice President, Global Franchise Head, Infection

David Vallo

Head of Alliance Management, BioPharmaceuticals R&D

Christer Gruvris

Executive Director of Investor Relations

Teresa Klinowska

Global Product Leader, Oncology R&D

Regina Fritsche-Danielson

Senior Vice President and Head of Research and Early Development, Cardiovascular, Renal and Metabolism (CVRM), BioPharmaceuticals R&D

Mikhail Kosiborod

Senior Vice President Late-Stage Development, Cardiovascular, Renal and Metabolism (CVRM), BioPharmaceuticals R&D, AstraZeneca

Ti Hwei How

Vice President, International Oncology

Victoria Parker

Executive Group Director, Metabolism, Early Clinical Development, Cardiovascular, Renal and Metabolism (CVRM), BioPharmaceuticals R&D, AstraZeneca

Sofia Tapani

Head of Early Respiratory & Immunology Statistics, Executive Director Statistics, AstraZeneca

Maurizio Scaltriti

Vice President, Translational Medicine, Early Oncology

Tom Keith-Roach

President, AstraZeneca UK

Lisa Hickey

Vice President, US Business Unit Lead Neurology

Femi D-Etti

Vice President & General Manager, Mount Vernon Supply, AstraZeneca

Caroline Austin

VP, UK and PMG Business Development

Joris Silon

US Country President, BioPharmaceuticals Business Unit

Aradhana Sarin

Executive Director and Chief Financial Officer

Per Alfredsson

Senior Vice President, Global Biologics Operations

Marc Dunoyer

Chief Executive Officer, Alexion and Chief Strategy Officer, AstraZeneca

Rasmus Jansson-Löfmark

Executive Director and Head of DMPK, Early CVRM, AstraZeneca

Elisabeth Björk

SVP, Late-Stage Development, Cardiovascular, Renal and Metabolism (CVRM), BioPharmaceuticals R&D

Michel Demaré

Non-Executive Chair of the Board

Philip Broadley

Senior independent Non-Executive Director

Peter Schell

Senior Director, Business Development PT&D

Tatiana Scetinina

Director, Data Science, AstraZeneca

Anna Sundgren

Global Development Leader, Lokelma & Bydureon

Sheri McCoy

Non-Executive Director

Tatiana Kubasova

Business Development Director, Russia & Eurasia

Paul Leon, PhD

Senior Director, Business Development, Search & Evaluation, and Partnering

Marcus Wallenberg

Non-Executive Director

Euan Ashley

Non-Executive Director

Birgit Conix

Non-Executive Director

Diana Layfield

Non-Executive Director

Rene Haas

Non-Executive Director

Richard Yuan

Associate Director, Corporate Development

Nazneen Rahman

Non-Executive Director

Nicolas Jose Guzman

Director Physician, Nephrology Clinical Research

Francesco Dazzi

Medical Lead Cell Therapies, BioPharmaceuticals R&D, AstraZeneca

Anna Manz

Non-Executive Director

Tony Mok

Non-Executive Director

Karen Knudsen

Non-Executive Director

Bing Chen

Vice President, International Business Development and Venture Fund

Aida Bendt

Head of Alliance Management

Brigitte de Lima

Senior Director, Corporate Development

Varun Malhotra

Director, Corporate Development

Gerardo Teja Rivera

Tower Lead for Global Supply Chain & Strategy and External Supply Manufacturing, Guadalajara GITC, AstraZeneca

Elizabeth Walton

Director of Investor Relations

Isabel Gibson

Director of Investor Relations

Ella Ekholm

Senior Medical Lead, Late-stage Development, Cardiovascular, Renal and Metabolism (CVRM), BioPharmaceuticals R&D

Louise Pearson

Director of Investor Relations